Fresolimumab is a human monoclonal antibody and an immunomodulator
localizing uPA's proteolytic activity and enhancing its enzymatic activity
and is also produced in activated macrophages
(2004) Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors
Expression System HEK293 Molecular Weight 23-30kDa Purity >95% by SDS-PAGE
IL-17A&IL-17F Heterodimer Protein, Rat Proteins and Enzymes Fresolimumab is a human monoclonalProduct Specification Species Rat Synonyms IL 17A, Interleukin 17A, CTLA 8, IL 17, IL 17F, Interleukin 17F, Cytokine ML 1, IL17A&IL17F Accession Q61453 (IL 17A)Q5BJ95 (IL 17F) Amino Acid Sequence Ala18 Ser150(IL 17A) Arg29 Ala161 (IL 17F) Expression System HEK293 Molecular Weight 12 25 kDa (Reducing) Purity >95% by SDS PAGE and HPLC. Endotoxin <0. 1EU g Conjugation Unconjugated Tag No Tag Physical Appearance Lyophilized Powder Storage Buffer PBS, pH7.